Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency. [electronic resource]
- Clinical and experimental immunology Aug 1981
- 344-51 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
0009-9104
Antigens--analysis Hormones--therapeutic use Humans Immunologic Deficiency Syndromes--drug therapy Infant Killer Cells, Natural--immunology Leukocyte Count Lymphocyte Activation Male Peptide Fragments--therapeutic use Receptors, Antigen, B-Cell--analysis Rosette Formation T-Lymphocytes--immunology Thymopentin Thymopoietins--therapeutic use Thymus Hormones--therapeutic use